abrdn Healthcare Opportunities Fund (THQ) Declares $0.18 Monthly Dividend with 10.91% Yield
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5d ago
0mins
Source: seekingalpha
- Monthly Dividend Announcement: abrdn Healthcare Opportunities Fund has declared a monthly dividend of $0.18 per share, payable on January 30, 2024, demonstrating its stable cash flow and commitment to shareholders.
- Yield Highlight: The fund boasts a forward yield of 10.91%, attracting income-seeking investors and reflecting the effectiveness of its investment strategy within the healthcare sector.
- Shareholder Record Date: The record date for shareholders is set for January 23, 2024, with the ex-dividend date also on January 23, ensuring that current shareholders can receive their dividends promptly, thereby boosting investor confidence.
- Market Performance Analysis: While abrdn Healthcare Opportunities Fund outperforms its peers, its limited growth potential suggests that investors should monitor its long-term return capabilities in relation to market volatility.
Analyst Views on THQ
Wall Street analysts forecast THQ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THQ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 19.790
Low
Averages
High
Current: 19.790
Low
Averages
High
No data
About THQ
abrdn Healthcare Opportunities Fund (the Fund), formerly Tekla Healthcare Opportunities Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. The Fund invests up to 20 % of managed assets, measured at the time of investment, in the debt of healthcare companies. The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. It invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics. The Fund's investment adviser is abrdn Inc.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
